Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
3.060
-0.350 (-10.26%)
At close: Jun 27, 2025, 4:00 PM
3.210
+0.150 (4.90%)
After-hours: Jun 27, 2025, 7:33 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $32.95 million as of June 27, 2025. Its market cap has decreased by -60.11% in one year.
Market Cap
32.95M
Enterprise Value
-29.45M
1-Year Change
-60.11%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $32.95M, a decrease of -98.69%. That is a compound annual growth rate of -57.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 40.05M | -42.16% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |